Prioritization for liver transplantation
暂无分享,去创建一个
Giacomo Germani | A. Burroughs | Evangelos Cholongitas | Andrew K. Burroughs | G. Germani | E. Cholongitas
[1] A. Burroughs,et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.
[2] M. Biselli,et al. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] R. Kalil,et al. Recommendations for the Assessment and Reporting of Multivariable Logistic Regression in Transplantation Literature , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] J. Trotter,et al. The International Normalized Ratio (INR) in the MELD Score: Problems and Solutions , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] G. Auzinger,et al. Increased model for end‐stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] W. Kim,et al. Organ allocation for chronic liver disease: model for end-stage liver disease and beyond , 2010, Current opinion in gastroenterology.
[7] J J Fung,et al. Liver Transplantation in the United States, 1999–2008 , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] T. Therneau,et al. Serum sodium, renal function, and survival of patients with end-stage liver disease. , 2010, Journal of hepatology.
[9] A. Burroughs,et al. Assessment of reproducibility of creatinine measurement and MELD scoring in four liver transplant units in the UK. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] R. Merion,et al. Effect of pretransplant serum creatinine on the survival benefit of liver transplantation , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[11] D. Segev,et al. Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] S. Feng,et al. Factors influencing liver transplant length of stay at two large‐volume transplant centers , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[13] J. Neuberger. The introduction of MELD‐based organ allocation impacts 3‐month survival after liver transplantation by influencing pretransplant patient characteristics , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[14] A. Burroughs,et al. Towards a better liver allocation system. , 2009, Journal of hepatology.
[15] M. Manns,et al. The introduction of MELD‐based organ allocation impacts 3‐month survival after liver transplantation by influencing pretransplant patient characteristics , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[16] M. Masetti,et al. Survival Benefit After Liver Transplantation: A Single European Center Experience , 2009, Transplantation.
[17] M. Lucey,et al. Disparities in liver transplantation in the post–model for end‐stage liver disease era: Are we there yet? , 2009, Hepatology.
[18] R. Merion,et al. Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit , 2009, Hepatology.
[19] E. Vittinghoff,et al. Ascites improves upon plus serum sodium model for end‐stage liver disease (MELD) for predicting mortality in patients with advanced liver disease , 2009, Alimentary pharmacology & therapeutics.
[20] C. Pilette,et al. Comparison and Improvement of MELD and Child-Pugh Score Accuracies for the Prediction of 6-month Mortality in Cirrhotic Patients , 2009, Journal of clinical gastroenterology.
[21] T. Therneau,et al. Impact of pretransplant hyponatremia on outcome following liver transplantation , 2009, Hepatology.
[22] F. Villamil,et al. Who should get a liver graft? , 2009, Journal of hepatology.
[23] J. Kalbfleisch,et al. Survival Benefit‐Based Deceased‐Donor Liver Allocation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[24] M. Navasa,et al. Clinically relevant differences in the model for end‐stage liver disease and model for end‐stage liver disease–sodium scores determined at three university‐based laboratories of the same area , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[25] Y. Cho,et al. Model for end‐stage liver disease, model for end‐stage liver disease‐sodium and Child–Turcotte–Pugh scores over time for the prediction of complications of liver cirrhosis , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[26] J. Perkins,et al. Should liver transplantation in patients with model for end‐stage liver disease scores ≤ 14 be avoided? A decision analysis approach , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[27] J. Perkins,et al. D‐MELD, a Simple Predictor of Post Liver Transplant Mortality for Optimization of Donor/Recipient Matching , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[28] R. Adam,et al. Liver transplantation: the current situation. , 2009, Seminars in liver disease.
[29] D. Axelrod,et al. Race and sex disparities in liver transplantation: progress toward achieving equal access? , 2008, JAMA.
[30] J. Tuttle-Newhall,et al. Disparities in liver transplantation before and after introduction of the MELD score. , 2008, JAMA.
[31] P. Ubel,et al. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. , 2008, Gastroenterology.
[32] C. Sima,et al. Re-weighting the model for end-stage liver disease score components. , 2008, Gastroenterology.
[33] T. Therneau,et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. , 2008, The New England journal of medicine.
[34] Samantha C Huo,et al. Comparison of four model for end‐stage liver disease–based prognostic systems for cirrhosis , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[35] Shou-Dong Lee,et al. Selecting an optimal prognostic system for liver cirrhosis: the model for end‐stage liver disease and beyond , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[36] D. Valla,et al. Assessment of Prognosis of Cirrhosis , 2008, Seminars in liver disease.
[37] E. Messou,et al. Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. , 2008, World journal of gastroenterology.
[38] Samantha C Huo,et al. Is the Corrected-Creatinine Model for End-Stage Liver Disease a Feasible Strategy to Adjust Gender Difference in Organ Allocation for Liver Transplantation? , 2007, Transplantation.
[39] M. Bartels,et al. Overview of the MELD score and the UNOS adult liver allocation system. , 2007, Transplantation proceedings.
[40] E. Cholongitas,et al. Review article: renal function assessment in cirrhosis – difficulties and alternative measurements , 2007, Alimentary pharmacology & therapeutics.
[41] A. Burroughs,et al. Selection of patients for liver transplantation and allocation of donated livers in the UK , 2007, Gut.
[42] D. Shawcross,et al. Meld score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation , 2007 .
[43] A. Gimson,et al. Development of a UK score for patients with end-stage liver disease , 2007 .
[44] Dharmendra P. Singh,et al. Applicability of MELD as a short‐term prognostic indicator in patients with chronic liver disease: An Indian experience , 2007, Journal of gastroenterology and hepatology.
[45] Shou-Dong Lee,et al. Correlation and Comparison of the Model for End-stage Liver Disease, Portal Pressure, and Serum Sodium for Outcome Prediction in Patients With Liver Cirrhosis , 2007, Journal of clinical gastroenterology.
[46] J. Bosch,et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[47] A. Tripodi,et al. The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end‐stage liver disease calculation , 2007, Hepatology.
[48] C. Sabin,et al. Towards a better liver transplant allocation system , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[49] Shou-Dong Lee,et al. Model for end‐stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[50] V. Arroyo,et al. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation , 2007, Gut.
[51] June-Sung Lee,et al. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month]. , 2007, The Korean journal of hepatology.
[52] E. Cholongitas,et al. Female Liver Transplant Recipients with the Same GFR as Male Recipients Have Lower MELD Scores—A Systematic Bias , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[53] W. Kim,et al. The model for end‐stage liver disease (MELD) , 2007, Hepatology.
[54] R. Fisher,et al. MELD‐XI: A rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[55] G. Ioannou,et al. Development and validation of a model predicting graft survival after liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[56] T. Gonwa,et al. Continued Influence of Preoperative Renal Function on Outcome of Orthotopic Liver Transplant (OLTX) in the US: Where Will MELD Lead Us? , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[57] Laura Marelli,et al. A systematic review of the performance of the model for end‐stage liver disease (MELD) in the setting of liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[58] N D Heaton,et al. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease , 2006, Gut.
[59] T. Therneau,et al. Evidence-based incorporation of serum sodium concentration into MELD. , 2006, Gastroenterology.
[60] F L Grover,et al. Development of the New Lung Allocation System in the United States , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[61] J. Bragg-Gresham,et al. Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[62] C. Sabin,et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome , 2006, The Lancet.
[63] F. Chang,et al. Proposal of a modified Child‐Turcotte‐Pugh scoring system and comparison with the model for end‐stage liver disease for outcome prediction in patients with cirrhosis , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[64] E. Cholongitas,et al. Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? , 2005, Alimentary pharmacology & therapeutics.
[65] Laura Marelli,et al. Different methods of creatinine measurement significantly affect MELD scores , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[66] I. Colle,et al. Impact of MELD on short-term and long-term outcome following liver transplantation: a European perspective , 2005, European journal of gastroenterology & hepatology.
[67] F. Chang,et al. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. , 2005, Journal of hepatology.
[68] E. Cholongitas,et al. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. , 2005, World journal of gastroenterology.
[69] D. Valla,et al. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. , 2005, Journal of hepatology.
[70] W. Kremers,et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[71] R. Wolfe,et al. The Survival Benefit of Liver Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[72] J. Hiatt,et al. MELD fails to measure quality of life in liver transplant candidates , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[73] Peter Bacchetti,et al. Serum sodium predicts mortality in patients listed for liver transplantation , 2005, Hepatology.
[74] T. Therneau,et al. Predicting Survival among Patients Listed for Liver Transplantation: An Assessment of Serial MELD Measurements , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[75] R. Freeman. Mathematical Models and Behavior: Assessing Delta MELD for Liver Allocation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[76] R. Fisher,et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death , 2004, Hepatology.
[77] M. Lucey. How will patients be selected for transplantation in the future? , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[78] J. Trotter,et al. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[79] E. Christensen. Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go? , 2004, Journal of hepatology.
[80] J. Neuberger. Allocation of donor livers — is MELD enough? , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[81] Mohamed Rela,et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[82] W. Chapman,et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function1 , 2004, Transplantation.
[83] L. Forman,et al. Predicting Outcome After Liver Transplantation: Utility of the Model for End-Stage Liver Disease and a Newly Derived Discrimination Function. , 2004 .
[84] R. Wiesner,et al. Results of the first year of the new liver allocation plan , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[85] A. Harper,et al. The sickest first? Disparities with model for end‐stage liver disease‐based organ allocation: One region's experience , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[86] A. Mihas,et al. Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. , 2003, Gastroenterology.
[87] M. Schemper. Predictive accuracy and explained variation , 2003, Statistics in medicine.
[88] W. Kim,et al. Is the change in MELD score a better indicator of mortality than baseline MELD score? , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[89] R. Wolfe,et al. Longitudinal assessment of mortality risk among candidates for liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[90] R. Wiesner,et al. The new liver allocation system: Moving toward evidence‐based transplantation policy , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[91] T M Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.
[92] P. Kamath,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.
[93] S. Schenker,et al. Portal systemic encephalopathy. , 1997, Clinics in liver disease.
[94] N. Madias,et al. Serum creatinine as an index of renal function: new insights into old concepts. , 1992, Clinical chemistry.
[95] R. Pugh,et al. Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.
[96] S. Sherlock,et al. Portal-systemic encephalopathy; neurological complications of liver disease. , 1954, Lancet.
[97] S. Sherlock,et al. Control of ascites in hepatic cirrhosis. , 1954, Lancet.
[98] E. Cholongitas,et al. Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[99] D. E. Schaubela,et al. The Survival Benefit of Deceased Donor Liver Transplantation as a Function of Candidate Disease Severity and Donor Quality , 2008 .
[100] R. Wiesner. Patient selection in an era of donor liver shortage: current US policy , 2005, Nature Clinical Practice Gastroenterology &Hepatology.
[101] P. Terasaki,et al. Liver transplantation in the United States. , 2005, Clinical transplants.
[102] R. Wiesner,et al. Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.
[103] C. Pine,et al. A European perspective. , 1996, Community dental health.
[104] D. Muley. The Indian experience , 1993, International review of education. Internationale Zeitschrift fur Erziehungswissenschaft. Revue internationale de pedagogie.
[105] N. Madias,et al. Serum creatinine and renal function. , 1988, Annual review of medicine.
[106] C. Goodman. United Network for Organ Sharing , 1988 .